ground elder
Selected indexed studies
- Dexamethasone in Hospitalized Patients with Covid-19. (N Engl J Med, 2021) [PMID:32678530]
- Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. (Lancet, 2021) [PMID:33933206]
- Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. (Lancet, 2022) [PMID:35908569]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Dexamethasone in Hospitalized Patients with Covid-19. (2021) pubmed
- Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. (2021) pubmed
- Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. (2022) pubmed
- Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. (2023) pubmed
- Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. (2024) pubmed
- Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. (2021) pubmed
- What counts as effective communication in nursing? Evidence from nurse educators' and clinicians' feedback on nurse interactions with simulated patients. (2014) pubmed
- Medico-religiousplantsusedbytheHajongcommunityofAssam,India. (2012) pubmed
- Indigenous Elder-centered methodology: research that decolonizes and indigenizes. (2023) pubmed
- Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. (2021) pubmed